Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mariona Hervas Pujol"'
Autor:
Armand Guàrdia Delgado, Aida Álvarez Pedrero, Maria Betriu Sabaté, Mariona Hervas Pujol, Wanda Natali Zabala Batista, José Antonio Monreal Ortiz, Javier Labad Arias, Diego José Palai Vidal
Publikováno v:
Psicosomática y Psiquiatría, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/dc9700e75b434ac5b242bc10089bc46f
Autor:
Itziar Abad, Mariona Hervas Pujol, Jordi Estela, Maria Luisa Viguera, Oriol Barrachina-Esteve, Gisela Ribera, Carlos Feijoo, Olalla Vazquez, Carme Lozano, Ana Paula Caresia
Publikováno v:
Neurology. 99:S74.2-S75
ObjectiveNA.BackgroundSarcoidosis is an immune mediated disorder characterized by the formation of non-necrotizing granulomas in multiple organs. The broad range of manifestations of sarcoidosis in the nervous system includes cranial neuropathy, meni
Autor:
José E. Meca-Lallana, José M. Prieto González, Ana B. Caminero Rodríguez, Javier Olascoaga Urtaza, Ana M. Alonso, Eduardo Durán Ferreras, Raúl Espinosa, Julio Dotor, Mercedes Romera, Adrián Ares Luque, Domingo Pérez Ruiz, Carmen Calles, Miguel A. Hernández, Miguel Hervás García, Amelia Mendoza Rodríguez, Yasmina Berdei Montero, Nieves Téllez, Nicolás Herrera Varó, Javier Sotoca, Silvia Presas-Rodríguez, Luis A. Querol Gutierrez, Mariona Hervás Pujol, Jordi Batlle Nadal, Gisela Martín Ozaeta, Laura Gubieras Lillo, Sergio Martínez Yélamos, Lluís Ramió-Torrentà, Javier Mallada Frechin, Antonio Belenguer Benavides, Francisco Gascón-Giménez, Bonaventura Casanova, Lamberto Landete Pascual, Leticia Berenguer, Laura Navarro, Montserrat Gómez Gutierrez, Carmen Durán, Ana Rodríguez Regal, Elena Álvarez, Daniel A. García-Estévez, Ana M. López Real, Miguel A. Llaneza González, María E. Marzo Sola, José L. Sánchez-Menoyo, Agustín Oterino, Ramón Villaverde González, Tamara Castillo-Triviño, Amaya Álvarez de Arcaya, Cristina Llarena
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 2177-2193 (2023)
Abstract Introduction Teriflunomide is a once-daily oral immunomodulator approved for relapsing forms of multiple sclerosis (MS) or relapsing–remitting multiple sclerosis (RRMS; depending on the local label), based on extensive evidence from clinic
Externí odkaz:
https://doaj.org/article/0d5e12714aa14ddbb6e6eadf49cbbed1